Please use this identifier to cite or link to this item:
Title: 3: Preventing complications of diabetes.
Austin Authors: Bate, Katherine L;Jerums, George 
Endocrinology Unit, Austin Health, Studley Road, Heidelberg, VIC 3084, Australia
Issue Date: 3-Nov-2003
Publication information: Medical Journal of Australia; 179(9): 498-503
Abstract: Diabetes complications are common and almost triple the annual cost of managing diabetes. Microvascular complications are the major risk in type 1 diabetes, while macrovascular complications are the major cause of morbidity and mortality in type 2 diabetes. Control of hyperglycaemia (target HbA(1c) level < or = 7%) and hypertension (target blood pressure < or = 130/80 mmHg) prevents microvascular complications in both types of diabetes; a multifactorial approach, comprising behaviour modification and pharmacological therapy for all risk factors, reduces the development of micro- and macrovascular complications in type 2 diabetes. The benefit of treating dyslipidaemia is at least as great in the diabetic population as in the non-diabetic population. Angiotensin-converting enzyme inhibitors and low-dose aspirin are indicated in people with diabetes and other cardiovascular risk factors. Regular annual screening for diabetes complications allows treatable disease to be identified. Aggressive management of hyperglycaemia and other risk factors can prevent many complications
Gov't Doc #: 14583083
Type: Journal Article
Subjects: Adult
Diabetes Mellitus, Type 1.complications
Diabetes Mellitus, Type 2.complications
Diabetic Angiopathies.prevention & control
Diabetic Nephropathies.prevention & control
Diabetic Neuropathies.prevention & control
Diabetic Retinopathy.prevention & control
Hemoglobin A, Glycosylated.analysis
Hypertension.drug therapy
Life Style
Risk Factors
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 28, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.